RCT: Real time remote symptom monitoring during chemotherapy for cancer may reduce symptom burden and improve quality of life.

Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART) – The BMJ

Commentaries:

Remote 24-hour monitoring shows sizable, positive effect on cancer patients – BMJ

Remote Monitoring System Reduces Chemotherapy Symptom Burden – HealthDay

eSMART trial adds support for remote symptom monitoring in people with cancer – medwire News

Related:

Study: Cancer patients benefit from using automated device to manage their symptoms

Study: Web-Based Symptom Monitoring Increases Overall Survival in Lung Cancer

#ASCO2017 – Survival in a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Cancer Treatment

Commentary on Twitter

👇🏼 Results from an RCT, conducted at multiple centres across Europe, showing the benefits of remote patient monitoring and highlighting the vital role it will play in services going forward – congratulations @roma_maguire @Lisa_McCann_ and colleagues https://t.co/8zWrykJEjS

— Katie McMillan (@KathrynMc91) July 22, 2021